Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ME

23andMe (ME) Stock Price, News & Analysis

23andMe logo

About 23andMe Stock (NASDAQ:ME)

Advanced Chart

Key Stats

Today's Range
$0.60
$1.10
50-Day Range
$0.50
$0.50
52-Week Range
$0.53
$9.57
Volume
29.28 million shs
Average Volume
1.55 million shs
Market Capitalization
$13.36 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

Receive ME Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 23andMe and its competitors with MarketBeat's FREE daily newsletter.

ME Stock News Headlines

A 23andMe saliva collection kit is shown on March 25, 2025, in Oakland, Calif
Anne Wojcicki's nonprofit gets court approval to buy 23andMe for $305 million
Anne Wojcicki's nonprofit, TTAM Research Institute, has received court approval to buy 23andMe — the genetic testing company she cofounded...
Bitcoin just humbled Jeff Bezos
Bitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. While the crowd buys Bitcoin outright, trader Larry Benedict is using a method called “Bitcoin Skimming” to target 6x, 9x, even 22x bigger profits. He reveals how it works in a free video.
See More Headlines

ME Stock Analysis - Frequently Asked Questions

23andMe Holding Co. (NASDAQ:ME) released its quarterly earnings results on Tuesday, January, 28th. The company reported ($1.02) earnings per share (EPS) for the quarter. 23andMe had a negative trailing twelve-month return on equity of 170.07% and a negative net margin of 183.39%.

23andMe shares reverse split on the morning of Wednesday, October 16th 2024.The 1-20 reverse split was announced on Friday, October 11th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, October 15th 2024. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that 23andMe investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), iShares Micro-Cap ETF (IWC) and DiamondRock Hospitality (DRH).

Company Calendar

Last Earnings
1/28/2025
Today
7/21/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ME
CIK
1804591
Fax
N/A
Employees
770
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($15.45)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$666.70 million
Net Margins
-183.39%
Pretax Margin
-186.76%
Return on Equity
-170.07%
Return on Assets
-62.13%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.05
Quick Ratio
0.91

Sales & Book Value

Annual Sales
$208.78 million
Price / Sales
0.06
Cash Flow
$0.54 per share
Price / Cash Flow
0.93
Book Value
$2.34 per share
Price / Book
0.21

Miscellaneous

Outstanding Shares
26,827,000
Free Float
19,766,000
Market Cap
$13.36 million
Optionable
Not Optionable
Beta
1.19
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:ME) was last updated on 7/22/2025 by MarketBeat.com Staff
From Our Partners